全球近视治疗市场 – 行业趋势及 2030 年预测

近视治疗市场分析及规模

主要因近视导致的视力丧失病例不断增加，以及由于未矫正近视导致的远距离视力障碍的发生率不断上升，是预计会增加整体市场增长的一些主要因素。大多数参与者还从事研发活动，开发用于治疗近视的药物。越来越多地使用数字渠道作为视觉手段是近视治疗市场的主要原因。近视通常在儿童和青少年时期发展，并且通常在 20 至 40 岁之间变得更加稳定。近视往往在家庭中遗传。

Data Bridge Market Research 分析了 2023-2030 年预测期内全球近视治疗市场的增长率。在上述预测期内，全球近视治疗市场的预期复合年增长率趋于 8% 左右。2022 年市场价值为 178.2 亿美元，到 2030 年将增长至 329.8 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

近视治疗市场范围和细分

Market Definition

Myopia, is also known as near-sightedness, is a type of eye condition wherein the eye fails to correctly refract light to a single focus on the retina. It has been observed that near objects are blurred because of this, objects in the distance are fuzzy. This can occur either due to the eyeball's size, which might be too long, or the cornea is shaped abnormally. In this regard, Texas Eye Surgeons, Plano's leading family of ophthalmologists, specializes in treating the large variety of eye-related disorders.

Global Myopia treatment Market Dynamics

Drivers

• Increasing R&D Activities

Most of the key market players are also engaged in R&D activities, to develop medications for the treatment of myopia treatment. For instance, on April 24, 2019, Sydnexis, Inc. initiated a phase 3 clinical trial study to assess the safety and effectiveness of SYD-101 sterile topical ophthalmic solution (atropine sulfate) in children having myopia. The approximate study completion time is July 2024. Furthermore, on June 3, 2019, Eyenovia Inc. initiated a phase 3 clinical trial study to assess myopia progression in participants using microdosed atropine 0.01%, atropine 0.1% or placebo ophthalmic solution. The study is projected to be completed in May 2024.

• Higher Demand of Hospitals

The rising demand of hospitals increase the market growth rapidly. Most ocular disease diagnostics are mainly carried out in hospitals as it requires technologically advanced products and thus this is driving the market for hospital/clinical laboratories.

Opportunities

• Rising Incidence of Myopia

Myopia is quite frequent during childhood, with a high prevalence of myopia, 80% to 90%, in young adults in East Asia. According to a study in the Investigative Ophthalmology and Visual Science journal, 2019, more than 32 % of the world's population has myopia, or nearsightedness, The study forecasts that by 2050, almost 60 % of the global population will have some level of myopia, mainly in highly developed countries.

• Presence of Key Market Players Focusing on Myopia Treatment

The presence of top marke players such as Carl Zeiss, Visioneering Technologies, Inc., and Alcon in Europe region is projected to boost the growth of the myopia treatment market, as these players are endlessly focusing on product development and launches. For instance, in February 2019, Visioneering Technologies, Inc. launched NaturalVue Brand Contact Lenses for myopia progression control & presbyopia in the U.K.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global myopia treatment market over a forecast period.

• High Cost

The huge expenditure required for setting up these techniques hamper the market growth. Numerous market players make huge investment in developing new and advanced machines to faster the process and in return the cost is increased.

This global myopia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global myopia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Myopia Treatment Market

During COVID-19, people already affected with myopia have started to go for telemedicine. With the extensive adoption of telemedicine, eye care professionals and regular specialists continue monitoring myopia progression, creating little impact on market growth. Several medical practices and hospitals are majorly affected during the COVID-19 pandemic due to several changes in protocols. The ophthalmology procedures are also affected in this novel disease outbreak as health checkups including ophthalmology were minimized because of COVID-19 restrictions. Many people choose LASIK surgery for vision correction due to the increased risk of spreading infection through contact lenses. Such reductions in elective ophthalmic surgeries are estimated to negatively impact the overall market growth.

Global Myopia Treatment Market

The global myopia treatment market is segmented on the basis of type, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Simple Myopia
• High Myopia
• Pathological Myopia

Treatment

• Eyeglasses
• Contact Lenses
• Refractive Surgery
• LASIK
• PRK
• Ortho-K

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

Global Myopia Treatment Market Regional Analysis/Insights

The global myopia treatment market is analyzed and market size insights and trends are provided by type, treatment, route of administration, end-user and distribution channel as referenced above.

全球近视治疗市场报告涉及的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于眼部疾病发病率高、医疗旅游业增长以及老年人口增加，北美占据了最大的市场份额。

由于政府宣传活动的加强和仿制药数量的增加，亚太地区在市场中占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局及全球近视治疗市场份额分析

全球近视治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球近视治疗市场的关注有关

全球近视治疗市场的主要参与者包括：

• HAAG-STREIT 集团（英国）
• 拓普康（日本）
• 尼德克株式会社（日本）
• EssilorLuxottica（法国）
• 库博集团 (美国)
• Bausch Health Companies Inc.（加拿大）
• 爱尔康 (美国)
• 蔡司国际（德国）
• 尼德克株式会社（日本）
• Ziemer Ophthalmic Systems (美国)

研究方法：全球近视治疗市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

SKU-55949